Advertisement
Research Article Free access | 10.1172/JCI114429
Institut National de la Santé et de la Recherche Medicale Unité 127, Hôpital Lariboisière, Paris, France.
Find articles by Mercadier, J. in: JCI | PubMed | Google Scholar
Institut National de la Santé et de la Recherche Medicale Unité 127, Hôpital Lariboisière, Paris, France.
Find articles by Lompré, A. in: JCI | PubMed | Google Scholar
Institut National de la Santé et de la Recherche Medicale Unité 127, Hôpital Lariboisière, Paris, France.
Find articles by Duc, P. in: JCI | PubMed | Google Scholar
Institut National de la Santé et de la Recherche Medicale Unité 127, Hôpital Lariboisière, Paris, France.
Find articles by Boheler, K. in: JCI | PubMed | Google Scholar
Institut National de la Santé et de la Recherche Medicale Unité 127, Hôpital Lariboisière, Paris, France.
Find articles by Fraysse, J. in: JCI | PubMed | Google Scholar
Institut National de la Santé et de la Recherche Medicale Unité 127, Hôpital Lariboisière, Paris, France.
Find articles by Wisnewsky, C. in: JCI | PubMed | Google Scholar
Institut National de la Santé et de la Recherche Medicale Unité 127, Hôpital Lariboisière, Paris, France.
Find articles by Allen, P. in: JCI | PubMed | Google Scholar
Institut National de la Santé et de la Recherche Medicale Unité 127, Hôpital Lariboisière, Paris, France.
Find articles by Komajda, M. in: JCI | PubMed | Google Scholar
Institut National de la Santé et de la Recherche Medicale Unité 127, Hôpital Lariboisière, Paris, France.
Find articles by Schwartz, K. in: JCI | PubMed | Google Scholar
Published January 1, 1990 - More info
A decrease in the myocardial level of the mRNA encoding the Ca2(+)-ATPase of the sarcoplasmic reticulum (SR) has been recently reported during experimental cardiac hypertrophy and failure. To determine if such a deficit occurs in human end-stage heart failure, we compared the SR Ca2(+)-ATPase mRNA levels in left (LV) and right ventricular (RV) specimens from 13 patients undergoing cardiac transplantation (6 idiopathic dilated cardiomyopathies; 4 coronary artery diseases with myocardial infarctions; 3 diverse etiologies) with control heart samples using a rat cardiac SR Ca2(+)-ATPase cDNA probe. We observed a marked decrease in the mRNA for the Ca2(+)-ATPase relative to both the 18S ribosomal RNA and the myosin heavy chain mRNA in LV specimens of patients with heart failure compared to controls (-48%, P less than 0.01 and -47%, P less than 0.05, respectively). The LV ratio of Ca2(+)-ATPase mRNA to 18S RNA positively correlated with cardiac index (P less than 0.02). The RV ratio correlated negatively with systolic, diastolic and mean pulmonary arterial pressures (P less than 0.02, P less than 0.02, and P less than 0.01, respectively). We suggest that a decrease of the SR Ca2(+)-ATPase mRNA in the myocardium plays an important role in alterations of Ca2+ movements and myocardial relaxation reported during human end-stage heart failure.
Images.